| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 23 |
| 1 | CYCLOPHOSPHAMIDE | 21 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 21 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 21 |
| 4 | CANAGLIFLOZIN | 18 |
| 5 | DAPAGLIFLOZIN | 17 |
| 6 | RITUXIMAB | 16 |
| 7 | TOCILIZUMAB | 16 |
| 8 | CARBOPLATIN | 14 |
| 9 | GLYBURIDE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FERROUS FUMARATE AND POLYSACCHRIDE IRON VITAMIN MINERAL COMPLEX SUPPLEMENT | 1 | 0.0051 |
| 1 | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | 1 | 0.0023 |
| 2 | FENOFIBRIC ACID | 1 | 0.0013 |
| 3 | VINBLASTINE SULFATE | 2 | 0.0010 |
| 4 | CEFTOLOZANE AND TAZOBACTAM | 1 | 0.0010 |
| 5 | EPLERENONE | 12 | 0.0009 |
| 6 | ROMIPLOSTIM | 11 | 0.0007 |
| 7 | SODIUM POLYSTYRENE SULFONATE | 1 | 0.0006 |
| 8 | COLISTIMETHATE SODIUM | 1 | 0.0006 |
| 9 | ANIDULAFUNGIN | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 51 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 2 | Alkylating Drug [EPC] | 25 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 18 |
| 4 | Sulfonylurea [EPC] | 18 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 16 |
| 6 | GLP-1 Receptor Agonist [EPC] | 16 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 16 |
| 8 | Platinum-based Drug [EPC] | 16 |
| 9 | Aldosterone Antagonist [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Monobactam Antibacterial [EPC] | 2 | 0.0007 |
| 1 | Thrombopoietin Receptor Agonist [EPC] | 11 | 0.0007 |
| 2 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 3 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 4 | Oxytocic [EPC] | 1 | 0.0003 |
| 5 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 7 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 8 | Penem Antibacterial [EPC] | 7 | 0.0002 |
| 9 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |